<DOC>
	<DOC>NCT02055547</DOC>
	<brief_summary>This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-8521. The primary hypothesis is that MK-8521 is sufficiently safe and well-tolerated in healthy, lean and obese males.</brief_summary>
	<brief_title>A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Males of either 18 to 45 or 45 to 70 years of age depending on the component of the study Body Mass Index between either 1825 or 3040 kg/m^2 depending on the component of the study Is in good health Is a nonsmoker and/or has not used nicotine for at least 3 months Is mentally or legally incapacitated, has significant emotional problems or has a history of psychiatric disorders in the past 5 years Has a history of the following abnormalities or diseases: endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological. History of cancer History of significant multiple or severe allergies or has had an anaphylactic reaction or significant intolerability to drugs or food Positive for hepatitis B surface antigen, hepatitis C antibodies or human immunodeficiency virus (HIV) Had major surgery, donated or lost 1 unit (500 mL) of blood or participated in another study within prior 4 weeks Has irritable bowel disease or recurrent nausea, vomiting, diarrhea or abdominal pain History of acute or chronic pancreatitis Uses 2 weeks prior to trial, or anticipates using during trial, medications, drugs or herbal remedies such as St. John's Wort Consumes greater than 3 glasses of alcohol per day Consumes greater than 6 servings of caffeinated beverages per day Regularly uses illicit drugs or has a history of drug (including alcohol) abuse within prior 3 months Has known hypersensitivity to glucagon or any glucagon like peptide 1 (GLP1) receptor agonist Is unwilling/unable to consume standardized meals and/or is on a carbohydrate restricted diet Has history of hypersensitivity to pharmacologic insulins</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>